MX2009008281A - Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion. - Google Patents

Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion.

Info

Publication number
MX2009008281A
MX2009008281A MX2009008281A MX2009008281A MX2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A
Authority
MX
Mexico
Prior art keywords
processes
metal ion
modified poly
preparation
hydroxy metal
Prior art date
Application number
MX2009008281A
Other languages
English (en)
Spanish (es)
Inventor
Jonathan Joseph Powell
Sylvaine Francoise Aline Bruggraber
Nuno Jorge Rodrigues Faria
Dora Isabel Amaral Pereira
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0702270.0A external-priority patent/GB0702270D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of MX2009008281A publication Critical patent/MX2009008281A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76—Metal complexes of amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00—Subject matter not provided for in other groups of this subclass

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
MX2009008281A 2007-02-06 2008-02-06 Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion. MX2009008281A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88838607P 2007-02-06 2007-02-06
GBGB0702270.0A GB0702270D0 (en) 2007-02-06 2007-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
PCT/GB2008/000408 WO2008096130A1 (en) 2007-02-06 2008-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

Publications (1)

Publication Number Publication Date
MX2009008281A true MX2009008281A (es) 2009-08-25

Family

ID=39204358

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008281A MX2009008281A (es) 2007-02-06 2008-02-06 Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion.

Country Status (15)

Country Link
US (1) US8058462B2 (enExample)
EP (1) EP2125847B1 (enExample)
JP (1) JP5756598B2 (enExample)
KR (1) KR101514470B1 (enExample)
AU (1) AU2008212653B2 (enExample)
BR (1) BRPI0807212B1 (enExample)
CA (1) CA2676146C (enExample)
CY (1) CY1116590T1 (enExample)
EA (1) EA019635B1 (enExample)
GB (1) GB2451713B (enExample)
HR (1) HRP20150944T1 (enExample)
IL (1) IL199901A (enExample)
MX (1) MX2009008281A (enExample)
PL (1) PL2125847T3 (enExample)
WO (1) WO2008096130A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2125847B1 (en) 2007-02-06 2015-06-17 Medical Research Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
GB201101299D0 (en) 2011-01-25 2011-03-09 Medical Res Council Oxygen sensors and their uses
GB201507002D0 (en) * 2015-04-24 2015-06-10 Medical Res Council Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
GB201517893D0 (en) * 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
JP7033545B2 (ja) * 2016-03-31 2022-03-10 シールド ティーエックス (ユーケー) リミテッド 配位子修飾及び配位子コーティングされた水酸化第二鉄からマルトール第二鉄組成物を生成するための方法
CN109311837B (zh) 2016-03-31 2022-09-30 英国神盾Tx股份有限公司 用于由氢氧化亚铁产生麦芽酚铁组合物的方法
JP7510254B2 (ja) 2016-08-10 2024-07-03 ユナイテッド キングダム リサーチ アンド イノベーション ナノシリカ粒子を含む組成物および療法のためにtリンパ球を活性化する方法におけるそれらの使用
SG11202001594TA (en) 2017-09-11 2020-03-30 Pharmacosmos Holding As Iron complex compounds for therapeutic use
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
WO2022061065A1 (en) * 2020-09-17 2022-03-24 Doyle Robert P Complexes of magnesium maltol (3-hydroxy-2-methyl-4h-pyran-4-one) for oral supplementation
AU2022323733A1 (en) 2021-08-03 2024-02-29 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL264270A (enExample) *
US2575347A (en) * 1949-07-14 1951-11-20 Interchem Corp Metallo organic compounds
GB959282A (en) * 1959-08-19 1964-05-27 Hardman & Holden Ltd Improvements relating to organic aluminium compounds
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3679377A (en) 1970-02-17 1972-07-25 Union Oil Co Iron complexes containing aquo,sulfate and hydroxyl ligands
US3821192A (en) 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
US4162986A (en) * 1977-06-20 1979-07-31 Mooney Chemicals, Inc. Oil-soluble high metal content transitional metal organic oxy, hydroxy, complexes
US4137359A (en) * 1977-10-31 1979-01-30 Mooney Chemicals, Inc. Elastomers with improved metal adhesion
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
US6177581B1 (en) 1999-10-12 2001-01-23 The Dow Chemical Company Mixed-metal chelates and process for the preparation thereof
US20030049284A1 (en) 2001-09-05 2003-03-13 Boccio Jose Ruben Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method
ES2357293T3 (es) 2001-10-08 2011-04-25 Purac Biochem N.V. Método de preparación de gluconato de calcio.
AU2003237552A1 (en) * 2002-01-24 2003-09-02 William Marsh Rice University Organic acid-feooh (ferroxane) particles and ferroxane-derived ceramics and ceramic membranes
US7994217B2 (en) 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US6706904B1 (en) 2002-12-04 2004-03-16 Albion International, Inc. Dimetalhydroxy malates
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US7964568B2 (en) 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
US7179939B2 (en) 2004-03-16 2007-02-20 Navinta Llc Sodium ferric gluconate complexes and method of manufacture thereof
WO2005094202A2 (en) 2004-03-16 2005-10-13 Navinta, Llc Iron sucrose complexes and method of manufacture thereof
BRPI0515847A (pt) 2004-10-08 2008-08-12 Unilever Nv uso de um complexo de ferro, composição alimentìcia, gênero alimentìcio fortificado com ferro, composição de bebida, bebida fortificada com ferro, suplemento alimentar e composição farmacêutica
DE202005014332U1 (de) 2005-09-09 2006-01-19 Institut für Oberflächenmodifizierung e.V. Metallorganisches Nanopulver
EP2125847B1 (en) 2007-02-06 2015-06-17 Medical Research Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
TWI592159B (zh) 2007-11-16 2017-07-21 威佛(國際)股份有限公司 藥學組成物
GB0814326D0 (en) 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses

Also Published As

Publication number Publication date
JP5756598B2 (ja) 2015-07-29
EP2125847B1 (en) 2015-06-17
IL199901A (en) 2014-11-30
GB0802214D0 (en) 2008-03-12
CA2676146A1 (en) 2008-08-14
CY1116590T1 (el) 2017-03-15
BRPI0807212A2 (pt) 2014-06-17
EP2125847A1 (en) 2009-12-02
US8058462B2 (en) 2011-11-15
BRPI0807212B1 (pt) 2022-01-11
PL2125847T3 (pl) 2015-12-31
GB2451713B (en) 2009-12-16
CA2676146C (en) 2016-08-09
JP2010520856A (ja) 2010-06-17
KR20090121281A (ko) 2009-11-25
US20080188555A1 (en) 2008-08-07
KR101514470B1 (ko) 2015-04-22
HK1138598A1 (en) 2010-08-27
AU2008212653A1 (en) 2008-08-14
WO2008096130A1 (en) 2008-08-14
IL199901A0 (en) 2010-04-15
GB2451713A (en) 2009-02-11
HRP20150944T1 (hr) 2015-10-09
EA019635B1 (ru) 2014-05-30
AU2008212653B2 (en) 2012-05-24
EA200970718A1 (ru) 2010-02-26

Similar Documents

Publication Publication Date Title
EA200970718A1 (ru) Лиганд-модифицированные полиоксогидроксидные материалы с ионами металла, их применение и способы их получения
WO2009111159A3 (en) Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
WO2004063342A3 (en) Cellular delivery and activation polypeptide-nucleic acid complexes
WO2005045394A3 (en) Silicone composition for biocompatible membrane
IL218317A (en) Use of 15-il polypeptide preparations and 15-il complexes for the preparation of cancer drugs
WO2007002662A3 (en) Anti-inflammatory, radioprotective, and longevity enhancing capabilities of cerium oxide nanoparticles
MX2009004707A (es) Piridina carboxamides como inhibidores 11-beta-hsd1.
EP2051572A3 (en) Housing for electronic components
WO2007043048A3 (en) Self-assembled fmoc-ff hydrogels
EP2145902A3 (en) Tyrosine phosphorylation sites and antibodies specific for them
IL185808A0 (en) Amide-substituted 8-n-benzimidazoles, metohd for the production thereof, and use of the same as medicaments
WO2008140594A3 (en) Peptide nanoparticles and uses therefor
MY154217A (en) Ingestible circuitry
EP3159018A3 (en) Gradient coating for biomedical applications
WO2007124302A3 (en) Bone graft composition
WO2010083385A3 (en) Compounds for reducing drug resistance and uses thereof
WO2009149339A3 (en) P53 activator peptides
MY156951A (en) Micromirs
EP2985281A3 (en) Isoindoline compounds for use in the treatment of cancer
WO2008151022A3 (en) Nucleic acid nanoparticles and uses therefor
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
WO2007098127A3 (en) Compositions for treating wounds and processes for their preparation
PL2234947T3 (pl) Produkt oparty na glicerynie, sposób jego otrzymywania i jego zastosowanie do wytwarzania dichloropropanolu
WO2010065329A3 (en) Nanoparticles for cancer treatment
WO2008101693A3 (en) Cosmetic and pharmaceutical applications of n-acylated amino acids and structurally related compounds

Legal Events

Date Code Title Description
FG Grant or registration